Status: Recruiting
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of Lutetium Lu 177 JH020002 Injection in adult patients with advanced prostate cancer.
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Bivision Pharmaceuticals, Inc.Updated: Oct 9, 2026Locations: 13
Eligibility criteria
Subjects are required to get informed consent prior to the trial and sign a writ... [+5]
Diagnosed with other malignancies, apart from: adequately treated skin basal cel... [+7]